Prediction of gestational diabetes early in pregnancy: targeting the long-term complications

Area of Science:

• Obstetrics and Gynecology
• Endocrinology
• Perinatal Medicine

Background:

• Gestational diabetes (GD) is carbohydrate intolerance recognized during pregnancy, affecting 7% of women globally.
• Increasing obesity rates contribute to higher pre-pregnancy insulin resistance, exacerbating GD risks.
• Infants of mothers with GD face elevated risks of macrosomia, birth trauma, NICU admission, and postnatal metabolic issues.

Purpose of the Study:

• To review current understanding of GD physiology.
• To examine established screening and treatment guidelines for GD.
• To advocate for multiparametric models for early GD risk stratification and complication prediction.

Main Methods:

• Review of current literature on gestational diabetes.
• Analysis of findings from the Hyperglycemia Adverse Pregnancy Outcome (HAPO) study.
• Discussion of existing clinical screening and treatment protocols.

Main Results:

• Gestational diabetes prevalence is 7% worldwide and rising.
• GD is linked to adverse infant outcomes, including macrosomia and metabolic disturbances.
• The HAPO study demonstrated a correlation between glycemic control and GD complications.

Conclusions:

• Effective management of GD is crucial for improving maternal and infant outcomes.
• Early identification and targeted interventions are key to mitigating GD-related risks.
• Developing multiparametric models combining clinical factors and biomarkers can enhance GD risk prediction.